ArticlePloS one2012

Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.

Lisa Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.